MedPath

Social Media Follow-up Nursing for Atopic Dermatitis

Not Applicable
Completed
Conditions
Atopic Dermatitis
Registration Number
NCT07142993
Lead Sponsor
The First Hospital of Hebei Medical University
Brief Summary

This is a randomized controlled study to evaluate the effectiveness of a social media-based (WeChat) networked nursing follow-up intervention compared to conventional nursing care for patients with atopic dermatitis. The study aims to determine the impact of the intervention on itch severity, skin condition, and self-care ability over a 6-month period.

Detailed Description

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that requires long-term management. Traditional outpatient care is often insufficient for managing the chronic nature of the disease. This study explores the effects of social media-based networked follow-up nursing interventions, leveraging popular platforms like WeChat to provide continuous support, personalized care plans, remote monitoring, and health education. This study prospectively enrolled and randomized 100 patients with AD into two groups: a research group receiving the social media-based intervention and a control group receiving conventional nursing care. The primary objective is to compare the differences in itch severity, eczema area and severity index (EASI), overall disease assessment (IGA), and self-care ability between the two groups from baseline to 6 months post-intervention. The study aims to provide evidence for social media-based nursing as an effective adjunctive management strategy for improving outcomes in patients with atopic dermatitis.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Aged 20-60 years;
  2. Diagnosed according to the Williams diagnostic criteria for atopic dermatitis;
  3. Signed informed consent.
Exclusion Criteria
  1. Severe, progressive, and uncontrolled major organ or systemic diseases (including cardiovascular, liver, lung, and kidney diseases), other autoimmune diseases, or malignant tumors;
  2. Pregnant or lactating women;
  3. Presence of other skin diseases;
  4. Mental health disorders;
  5. Previous experience with similar follow-up nursing interventions;
  6. Severe complications such as infections or allergies.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Itch SeverityBaseline, 6 Months

Measured by the Numeric Rating Scale (NRS) for itching. The scale ranges from 0 (no itching) to 10 (very severe itching), where patients rate the most severe itching experienced in the past 24 hours. A higher score indicates more severe itching.

Change in Self-care AbilityBaseline, 6 Months

Measured by the Exercise of Self-Care Agency Scale (ESCA). The scale includes 43 items across four dimensions (self-care skills, self-responsibility, self-concept, and health knowledge). It uses a Likert 5-point scoring system (0 to 4 points). A higher total score indicates stronger self-care ability.

Secondary Outcome Measures
NameTimeMethod
Change in Eczema Area and Severity Index (EASI)Baseline, 6 Months

EASI is used to evaluate the eczema area and severity. It assesses four clinical signs (erythema, papules/edema, lichenification, epidermal peeling) on a scale of 0 to 3 based on severity. A higher score indicates greater disease severity.

Change in Overall Evaluation ScoreBaseline, 6 Months

Measured by the Investigator's Global Assessment (IGA). A six-level scoring system (0 to 5) is used, where 0 indicates no lesions and 5 indicates very severe disease. A higher score indicates greater overall disease severity.

Trial Locations

Locations (1)

the Second Hospital of Hebei Medical University

🇨🇳

Shijiazhuang, Hebei, China

the Second Hospital of Hebei Medical University
🇨🇳Shijiazhuang, Hebei, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.